ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 161,47
-0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) Actualités

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:ROQ
DateHeureSourceTitreSymboleSociété
04/06/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Notice of Annual General MeetingLSE:ROQRoquefort Therapeutics Plc
23/05/202422h25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202408h05RNS Regulatory NewsRoquefort Therapeutics PLC Issue of Convertible Loan Notes & Board ChangesLSE:ROQRoquefort Therapeutics Plc
23/05/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Midkine Antibody Licencing DealLSE:ROQRoquefort Therapeutics Plc
26/04/202421h59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
05/04/202413h32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
11/03/202412h12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
06/02/202417h50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
24/11/202308h00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
06/11/202313h01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202308h00UK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
27/09/202316h43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202308h00UK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
22/09/202312h42RNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
14/08/202312h07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202308h00UK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
07/08/202312h04Alliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
07/08/202308h00UK RegulatoryRoquefort Therapeutics PLC Development of New Novel siRNA TherapeuticsLSE:ROQRoquefort Therapeutics Plc
02/08/202308h00UK RegulatoryRoquefort Therapeutics PLC Director/PDMR ShareholdingLSE:ROQRoquefort Therapeutics Plc
29/06/202319h51Alliance NewsAlliance NewsTRADING UPDATES: Anpario trading in line, Likewise Group sales riseLSE:ROQRoquefort Therapeutics Plc
29/06/202311h05UK RegulatoryRoquefort Therapeutics PLC Results of AGMLSE:ROQRoquefort Therapeutics Plc
29/06/202308h00UK RegulatoryRoquefort Therapeutics PLC AGM StatementLSE:ROQRoquefort Therapeutics Plc
22/06/202321h34Alliance NewsAlliance NewsTRADING UPDATES: Plant Health Care announces GBP2.8 million fundraiseLSE:ROQRoquefort Therapeutics Plc
22/06/202308h00UK RegulatoryRoquefort Therapeutics PLC RNA Medicine Shows In Vitro Anti-Cancer EfficacyLSE:ROQRoquefort Therapeutics Plc
19/06/202313h28Alliance NewsAlliance NewsRoquefort Therapeutics celebrates cancer antibody trial resultsLSE:ROQRoquefort Therapeutics Plc
19/06/202308h00UK RegulatoryRoquefort Therapeutics PLC Antibody Program Results & Orphan Drug IndicationLSE:ROQRoquefort Therapeutics Plc
 Showing the most relevant articles for your search:LSE:ROQ

Dernières Valeurs Consultées

ASX
STWSWA
LSE
SKYA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés